Watchmaker Genomics
PrivateLast Round
Series A
Jun 2, 2022
Est. Valuation
$242.25M
Total Funding Raised
$53.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Watchmaker Genomics is a biotechnology company that develops high-performance tools for genomics, molecular diagnostics, and personalized medicine by combining computational biology, protein engineering, and large-scale enzyme manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Watchmaker Genomics Comparables
Compare Watchmaker Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Paragon Genomics | 82% | |
| SeqWell | 80% | |
| biomodal | 79% |
Watchmaker Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 2, 2022 | ||||
| Seed | Dec 4, 2020 |
Key People
Founding team and executive leadership
Watchmaker Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eclipse Ventures | Series A |
| Decheng Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 24, 2026
Achieved ISO 13485 compliance for its Quality Management System.
- Apr 20, 2026
Attended ESCMID Global congress to showcase infectious disease diagnostics.
Recent news
Latest coverage and updates
- expands_facilitiesSep 1, 2026
Watchmaker Genomics, Inc. will expand facilities to Colorado, United States, Northern America, Americas on Oct 1st '27.
- expands_facilitiesSep 1, 2026
Watchmaker Genomics, Inc. expanded facilities to Boulder, Colorado, United States, Northern America, Americas on Sep 1st '26.
- expands_facilitiesSep 1, 2026
Watchmaker Genomics, Inc. will expand facilities to Boulder, Colorado, United States, Northern America, Americas on Oct 1st '27.
Watchmaker Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Watchmaker Genomics's valuation, stock price, and market status.
Is Watchmaker Genomics a public or private company?
Watchmaker Genomics is a private company.
What is the current stock price of Watchmaker Genomics?
Watchmaker Genomics is a private company with no public stock price. No recent secondary market data is available.
How much is Watchmaker Genomics worth (valuation)?
Watchmaker Genomics's valuation is estimated at $242.3M based on funding round data.
Can I buy Watchmaker Genomics stock?
Watchmaker Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Watchmaker Genomics's last funding round?
Watchmaker Genomics's most recent funding round was Series A on June 2, 2022.
Who are the main investors in Watchmaker Genomics?
Key investors in Watchmaker Genomics include Decheng Capital.
Will Watchmaker Genomics IPO soon?
No public IPO plans have been announced for Watchmaker Genomics.
How can I track Watchmaker Genomics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Watchmaker Genomics's secondary market activity and sign up for updates.